Daigen Xu
About
Daigen Xu is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Daigen Xu has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daigen Xu's work include Inflammatory mediators and NSAID effects (11 papers), Cell death mechanisms and regulation (7 papers) and Synthesis of β-Lactam Compounds (4 papers). Daigen Xu is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Cell death mechanisms and regulation (7 papers) and Synthesis of β-Lactam Compounds (4 papers). Daigen Xu collaborates with scholars based in Canada, United States and Italy. Daigen Xu's co-authors include George S. Robertson, Donald W. Nicholson, Patsy Clark, Sophie Roy, Robert Zamboni, Robert G. Korneluk, John P. Vaillancourt, Steven Xanthoudakis, Stephen J. Crocker and Peter Liston and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.
In The Last Decade
Daigen Xu
36 papers receiving 2.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Daigen Xu Canada | 23 | 1.4k | 668 | 556 | 474 | 319 | 36 | 2.8k | ||
| Michael D. Knierman United States | 24 | 1.5k 1.1× | 459 0.7× | 594 1.1× | 449 0.9× | 137 0.4× | 43 | 3.2k | ||
| Klaus van Leyen United States | 37 | 2.1k 1.5× | 404 0.6× | 413 0.7× | 499 1.1× | 146 0.5× | 74 | 4.3k | ||
| Shuh Narumiya Japan | 18 | 1.5k 1.1× | 1.3k 2.0× | 533 1.0× | 420 0.9× | 659 2.1× | 21 | 3.5k | ||
| Richard J. Haslam Canada | 37 | 2.2k 1.6× | 486 0.7× | 867 1.6× | 351 0.7× | 266 0.8× | 79 | 4.3k | ||
| Tomoyuki Nishizaki Japan | 29 | 1.3k 1.0× | 218 0.3× | 583 1.0× | 529 1.1× | 139 0.4× | 120 | 2.7k | ||
| Alice Lin United States | 8 | 2.3k 1.7× | 446 0.7× | 613 1.1× | 372 0.8× | 359 1.1× | 15 | 3.6k | ||
| Enno Klußmann Germany | 40 | 3.5k 2.5× | 345 0.5× | 300 0.5× | 386 0.8× | 228 0.7× | 92 | 4.1k | ||
| Chakkodabylu S. Ramesha United States | 11 | 1.2k 0.9× | 534 0.8× | 340 0.6× | 242 0.5× | 230 0.7× | 13 | 2.2k | ||
| Chunjiang Yu United States | 26 | 1.6k 1.2× | 363 0.5× | 1.5k 2.7× | 519 1.1× | 351 1.1× | 46 | 3.5k | ||
| Nicole Defer France | 30 | 2.2k 1.6× | 263 0.4× | 360 0.6× | 710 1.5× | 245 0.8× | 81 | 3.1k |
Countries citing papers authored by Daigen Xu
Since
Specialization
Citations
This map shows the geographic impact of Daigen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daigen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daigen Xu more than expected).
Fields of papers citing papers by Daigen Xu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daigen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daigen Xu. The network helps show where Daigen Xu may publish in the future.
Co-authorship network of co-authors of Daigen Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Daigen Xu. A scholar is included among the top collaborators of Daigen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daigen Xu. Daigen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bender, Andrew T., Albertina Pereira, Kai Fu, et al.. (2016). Btk inhibition treats TLR7/IFN driven murine lupus. Clinical Immunology. 164. 65–77.
2.
Xu, Daigen, Yong Kim, Jennifer Postelnek, et al.. (2012). RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents. Journal of Pharmacology and Experimental Therapeutics. 341(1). 90–103.
3.
Boulet, Louise, Christine Brideau, David Claveau, et al.. (2011). Trisubstituted ureas as potent and selective mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1488–1492.
4.
Baragatti, Barbara, et al.. (2011). Dual, Constrictor-to-Dilator, Response of the Mouse Ductus Arteriosus to the Microsomal Prostaglandin E Synthase-1 Inhibitor, 2-(6-Chloro-1H-phenanthro[9,10<i>d</i>]imidazole- 2-yl)isophthalonitrile. Neonatology. 100(2). 139–146.
5.
Colucci, John, Michael J. Boyd, Carl Berthelette, et al.. (2010). Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl)amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 20(12). 3760–3763.
6.
Burch, Jason D., John Colucci, Claudio F. Sturino, et al.. (2010). Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 21(3). 1041–1046.
7.
Cauchon, Elizabeth, Susana Liu, M. David Percival, et al.. (2009). Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology. Analytical Biochemistry. 388(1). 134–139.
8.
Chen, Mei, Éric Boilard, Peter A. Nigrović, et al.. (2008). Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody‐driven K/BxN serum–transfer arthritis. Arthritis & Rheumatism. 58(5). 1354–1365.
9.
Clark, Patsy, Danielle Denis, Marie‐Claude Mathieu, et al.. (2008). MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7 H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a Selective E Prostanoid Receptor 4 Antagonist, Relieves Joint Inflammation and Pain in Rodent Models of Rheumatoid and Osteoarthritis. Journal of Pharmacology and Experimental Therapeutics. 325(2). 425–434.
10.
Côté, Bernard, Louise Boulet, Christine Brideau, et al.. (2007). Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6816–6820.
11.
Clark, Patsy, Robert J. Gordon, Jocelyne Guay, et al.. (2007). Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species. European Journal of Pharmacology. 560(2-3). 216–224.
12.
Pulichino, Anne-Marie, Steve Rowland, Tom Wu, et al.. (2006). Prostacyclin Antagonism Reduces Pain and Inflammation in Rodent Models of Hyperalgesia and Chronic Arthritis. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1043–1050.
13.
Bureau, Y, France Laliberté, Craig S. Moore, et al.. (2006). Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline. Neuropharmacology. 51(5). 974–985.
14.
Davoli, Maria Antonietta, James P. Tam, Steven Xanthoudakis, et al.. (2002). Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience. 115(1). 125–136.
15.
Schwab, Birgit, Danilo Guerini, Claire Didszun, et al.. (2002). Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death and Differentiation. 9(8). 818–831.
16.
Han, Byung Hee, Daigen Xu, Junjeong Choi, et al.. (2002). Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury. Journal of Biological Chemistry. 277(33). 30128–30136.
17.
Davoli, Maria Antonietta, Yubo Ren, C. Jones, et al.. (2002). Automated analysis of global ischemia-induced CA1 neuronal death using terminal UTP nick end labeling (TUNEL). Journal of Neuroscience Methods. 115(1). 55–61.
18.
Gervais, François G., Daigen Xu, George S. Robertson, et al.. (1999). Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation. Cell. 97(3). 395–406.
19.
Xu, Daigen, Stephen J. Crocker, J. P. Doucet, et al.. (1997). Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Medicine. 3(9). 997–1004.
20.
Xu, Daigen, et al.. (1991). DNA binding of methyl iodide in male and female F344 rats. Carcinogenesis. 12(3). 463–467.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Michael D. Knierman Breakdown of academic impact, for papers by Klaus van Leyen Breakdown of academic impact, for papers by Shuh Narumiya Breakdown of academic impact, for papers by Richard J. Haslam Breakdown of academic impact, for papers by Tomoyuki Nishizaki Breakdown of academic impact, for papers by Alice Lin Breakdown of academic impact, for papers by Enno Klußmann Breakdown of academic impact, for papers by Chakkodabylu S. Ramesha Breakdown of academic impact, for papers by Chunjiang Yu Breakdown of academic impact, for papers by Nicole Defer